Skip to content
Search

Latest Stories

WHO cautions against self-medication with ibuprofen for COVID-19 symptoms

The World Health Organization recommended Tuesday that people suffering from COVID-19-like symptoms should avoid self-medicating with ibuprofen, after French authorities warned anti-inflammatory drugs could worsen the effects of the virus.


The warnings over the weekend by French Health Minister Olivier Veran followed a recent study in The Lancet weekly medical journal that hypothesised that an enzyme that is boosted when taking anti-inflammatory drugs like ibuprofen could facilitate and worsen COVID-19 infections.

Asked about the study, WHO spokesman Christian Lindmeier told reporters in Geneva that the UN health agency's experts were "looking into this to give further guidance."

"In the meantime, we recommend using rather paracetamol, and do not use ibuprofen as a self-medication. That's important," he said.

He stressed though that if ibuprofen had been "prescribed by the healthcare professionals, then, of course, that's up to them."

His comments came after Veran sent a tweet cautioning that the use of ibuprofen and similar anti-inflammatory drugs could be "an aggravating factor" in COVID-19 infections.

"In the case of fever, take paracetamol," he wrote.

He stressed that patients already being treated with anti-inflammatory drugs, should "ask advice from your doctor."

Paracetamol must be taken strictly according to the dose, because too high a dosage can be very dangerous for the liver.

The COVID-19 pandemic, which has infected more than 180,000 people worldwide and killed more than 7,000, causes mild symptoms in most people, but can result in pneumonia and in some cases severe illness that can lead to multiple organ failure.

Even before the pandemic, French authorities last year sounded the alarm over serious "infectious complications" linked to the use of ibuprofen, which is sold under various brands like Nurofen and Advil, and other anti-inflammatory drugs.

More For You

Infant formula: Food, diet and obesity committee welcomes CMA proposals, demands action on processed foods
CMA study shows that parents could save around £300 a year by switching to a lower priced infant formula brand (gettyimages)

Infant formula: CMA calls for stronger labelling and advertising rules

All infant formula brands should be displayed together and separately from other formula milks in stores to enable quick and easy price comparisons – suggests CMA 

The Competition and Marketing Authority (CMA) has recommended the governments of the four UK nations to strengthen advertising and labelling rules of infant formula to help parents make informed decisions and save money.

Keep ReadingShow less
David Thomas Steps In as NPA’s New Wales Representative
Five NPA members are contesting for the remaining position in England (gettyimages)

NPA board update: David Thomas succeeds Raj Aggarwal OBE

Five NPA members are contesting for the remaining position in England

David Thomas, owner of LT Chemists in Newport, will replace Raj Aggarwal OBE as the next National Pharmacy Association (NPA) board member for Wales, following an uncontested election this month.

Keep ReadingShow less
Public Policy Projects calls for better use of community pharmacy skill mix to improve medicines adherence
Non-adherence to medicines remains a critical issue, with an estimated 30 to 50 per cent of medicines for long-term conditions not taken as prescribed. (gettyimages)

Leverage pharmacy skill mix to improve medicines adherence - report suggests

The report also suggested expanding the community pharmacy contractual framework to enable community pharmacy to deliver medicines reviews

Pharmacy technicians and assistants should be enabled to talk to patients about their medications to improve medicines adherence, a new report has recommended.

Keep ReadingShow less
Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Pharmacy contract consultation to review medicine margin and reimbursement, says Kinnock

Kinnock confirms that an announcement on the 2025/26 GP contract would be made before April 2025

The 2025/26 pharmacy contract consultation will include a review of the medicine margin and reimbursement arrangements, health and care minister Stephen Kinnock has confirmed.

Keep ReadingShow less
NPA urges immediate release of pharmacy funding crises review
Underfunding has forced record numbers of pharmacy closures (gettyimages)

Suppressing pharmacy funding crisis analysis would be ‘outrageous’, warns NPA

The NPA fears the report won’t be published until pharmacy funding consultations conclude, while CPE states there is no set timeline for finalising negotiations.

The National Pharmacy Association (NPA) has called on the NHS and the Department of Health to immediately publish the government-commissioned analysis of pharmacy underfunding and reveal the true scale of the crisis.

Keep ReadingShow less